Quick Answer
Altimmune, Inc. reported Earnings Per Share Diluted of $1.00 (loss) per share for the year ending 2025.
- Altimmune, Inc. showed an increase of +25.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Altimmune, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
- XBRL data for this metric is available from 2014 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2014 to 2025), Altimmune, Inc.'s Earnings Per Share Diluted has declined by 488.2%.
- Historical annual values: Fiscal year 2025: $1.00 (loss) per share | Fiscal year 2024: $1.34 (loss) per share | Fiscal year 2023: $1.66 (loss) per share | Fiscal year 2022: $1.81 (loss) per share | Fiscal year 2021: $2.35 (loss) per share | Fiscal year 2020: $1.91 (loss) per share | Fiscal year 2016: $2.95 per share | Fiscal year 2015: $0.05 (loss) per share | Fiscal year 2014: $0.17 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: